Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors

European Journal of Pharmacology

Volumn 148, Issue 2, 1988, Pages 221-229

  Vasse, Marc ^a   Chagraoui, Abdeslam ^a   Protais, Philippe ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

(Mouse); Climbing behaviour; Dopamine D 1 receptors; Dopamine D 2 receptors; LY17155; Ru 24926; SCH 23390; SK F 38393; Stereotyped behaviours

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; BROMOCRIPTINE; DOPAMINE; LERGOTRILE; METOCLOPRAMIDE; N,N BIS(3 HYDROXYPHENETHYL)PROPYLAMINE; PIRIBEDIL; QUINPIROLE;

ANIMAL EXPERIMENT; BEHAVIOR; CLIMBING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PSYCHOLOGICAL ASPECT; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ANTIPSYCHOTIC AGENTS; APOMORPHINE; APPETITE DEPRESSANTS; BEHAVIOR, ANIMAL; BENZAZEPINES; BROMOCRIPTINE; ERGOLINES; MALE; MICE; MICE, INBRED STRAINS; PIRIBEDIL; QUINPIROLE; RECEPTORS, DOPAMINE; SCH-23390; SK&F-38393; STEREOTYPED BEHAVIOR;

EID: 0023832391     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(88)90567-5     Document Type: Article

References (40)

1. Evidence for dopamine receptor stimulation by apomorphine
2. Interaction of SCH 23390, a D-1 selective antagonist, with the anterior pituitary D-2 receptors and prolactine secretion in the rat
3. 1 receptor agonists and antagonists
4. Dopaminergic receptors in the anterior pituitary gland
5. Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity
6. Piribedil: behavioural, neurochemical and clinical profile of a dopamine agonist
7. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats
8. Activity of two potent dopaminergic agonists at the striatal and anterior of two potent dopaminergic agonists at the striatal and anterior pituitary levels
9. Interaction of ergot drugs with central monoamine systems
10. 2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states
11. Effects of three dopamine agonists on cage climbing behavior
12. The affinities of ergot compounds for dopamine agonist and dopamine antagonist receptor sites
13. 1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in rats
14. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems
15. TL 333, a benzhydro/g/quinoline, stimulates both D-1 and D-2 dopamine receptors: implications for the selectivity of LY141865 towards the D-2 receptor
16. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates
17. Dopamine-sensitive adenylyl cyclase: a receptor mechanism for dopamine
18. Multiple receptors for dopamine
19. The pituitary dopamine receptor
20. A simplified method of evaluating dose-effects experiments
21. Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2 mediated behavioural responses yawning in rats
22. A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice
23. Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies
24. Selection of dopamine antagonists discriminating various behavioural responses and radioligand binding sites
25. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain
26. 1 antagonist SCH 23390
27. Catalepsy induced by SCH 23390 in rats
28. Climbing behaviour by apomorphine in mice: a simple test for the study of dopamine receptors in striatum
29. Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats
30. Dopaminergic behavioural responses and classes of binding sites distinguished by discriminant benzamide derivatives
31. Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitary
32. Biochemical and behavioral identification of disciminant benzamide derivatives: new tools to differentiate subclasses of dopamine receptors
33. Distinction of dopamine receptors well recognized by antipsychotic agents: binding, autoradiographic and behavioural studies
34. Brain dopamine receptors
35. The central effects of a novel dopamine agonist
36. 3H-domperidone binding sites differ in rat striatum and pituitary
37. 3H-domperidone
38. Effects of bromocriptine on central dopaminergic receptors
39. Evidence that LY 141865 specifically stimulates the D-2 dopamine receptor
40. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice